# How Important Are Hematological Parameters in the Prognosis of Severe Covid-19 Patients?

> **NCT05650944** · — · COMPLETED · sponsor: **Hisar Intercontinental Hospital** · enrollment: 125 (actual)

## Conditions studied

- COVID-19

## Interventions

- **DIAGNOSTIC_TEST:** Hemogram

## Key facts

- **NCT ID:** NCT05650944
- **Lead sponsor:** Hisar Intercontinental Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-03-01
- **Primary completion:** 2021-12-31
- **Final completion:** 2022-09-30
- **Target enrollment:** 125 (ACTUAL)
- **Last updated:** 2022-12-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05650944

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05650944, "How Important Are Hematological Parameters in the Prognosis of Severe Covid-19 Patients?". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05650944. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*